NEUROCRINE BIOSCIENCES INC (NBIX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for NBIX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NBIX | Director | 60 | ["Healthcare Industry","Biotech and Pharma Operations Expertise","Governance","Investor Relations","Public Policy","Executive Leadership"] | ["Nominating /Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| CVS | Strategic Counsel at Epstein Becker & Green P.C.; Director | 60 | ["Strategic Counsel at Epstein, Becker & Green, P.C.", "Advises companies through EBG Advisors", "Advisor to private equity investors", "Former Acting Administrator for the U.S. Centers for Medicare & Medicaid Services", "Deep knowledge of the health care industry and related government regulations", "Experience with corporate governance, health care compliance and risk management", "extensive expertise in health care", "former Acting Administrator of CMS"] | ["HS&T", "PP&EA", "Health Services and Technology", "Public Policy and External Affairs", "Health Services and Technology Committee"] | 2026 |
| CNC | Director | ["Extensive legal, regulatory and political, and healthcare expertise", "Strategic Counsel, Epstein Becker Green, P.C.", "Advisor to three private equity firms in healthcare policy and regulatory matters", "Former Director of Magellan Health"] | ["Compliance Committee", "ESHG Committee", "Government and Regulatory Affairs Committee"] | 2022 |